AU538054B2 - Tricyclic ethers - Google Patents

Tricyclic ethers

Info

Publication number
AU538054B2
AU538054B2 AU69340/81A AU6934081A AU538054B2 AU 538054 B2 AU538054 B2 AU 538054B2 AU 69340/81 A AU69340/81 A AU 69340/81A AU 6934081 A AU6934081 A AU 6934081A AU 538054 B2 AU538054 B2 AU 538054B2
Authority
AU
Australia
Prior art keywords
general formula
dibenzo
dioxepin
optical isomers
addition salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU69340/81A
Other languages
English (en)
Other versions
AU6934081A (en
Inventor
Charles Malen
Jean-Claude Poignant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union et Cie filed Critical Science Union et Cie
Publication of AU6934081A publication Critical patent/AU6934081A/en
Application granted granted Critical
Publication of AU538054B2 publication Critical patent/AU538054B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU69340/81A 1980-04-10 1981-04-09 Tricyclic ethers Ceased AU538054B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8008023A FR2480283A1 (fr) 1980-04-10 1980-04-10 Nouveaux derives tricycliques, leurs procedes de preparation et leur utilisation comme medicament
FR8008023 1980-04-10

Publications (2)

Publication Number Publication Date
AU6934081A AU6934081A (en) 1981-10-15
AU538054B2 true AU538054B2 (en) 1984-07-26

Family

ID=9240699

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69340/81A Ceased AU538054B2 (en) 1980-04-10 1981-04-09 Tricyclic ethers

Country Status (23)

Country Link
US (1) US4459306A (enExample)
EP (1) EP0041410B1 (enExample)
JP (1) JPS56158780A (enExample)
AR (1) AR229026A1 (enExample)
AT (1) ATE5257T1 (enExample)
AU (1) AU538054B2 (enExample)
CA (1) CA1181068A (enExample)
DD (1) DD158242A5 (enExample)
DE (1) DE3161358D1 (enExample)
DK (1) DK159981A (enExample)
ES (2) ES8306483A1 (enExample)
FI (1) FI811059A7 (enExample)
FR (1) FR2480283A1 (enExample)
GR (1) GR75194B (enExample)
IL (1) IL62622A (enExample)
MA (1) MA19113A1 (enExample)
NO (1) NO811229L (enExample)
NZ (1) NZ196774A (enExample)
OA (1) OA06779A (enExample)
PT (1) PT72833B (enExample)
SU (1) SU1106444A3 (enExample)
YU (1) YU92481A (enExample)
ZA (1) ZA812379B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2094790B (en) * 1981-03-13 1985-10-09 Spofa Vereinigte Pharma Werke Tricycle compounds
CA1208653A (en) * 1982-09-30 1986-07-29 Pierre Hamel 6h-dibenz [b,e] [1,4] oxathiepin derivatives
ATE167057T1 (de) * 1994-03-02 1998-06-15 Akzo Nobel Nv Sublinguales oder bukkales arzneimittel
JP4006796B2 (ja) 1997-11-17 2007-11-14 株式会社日立製作所 個人情報管理方法および装置
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US6683072B1 (en) 2003-02-04 2004-01-27 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia
US20050227961A1 (en) * 2004-04-08 2005-10-13 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN111377901A (zh) * 2018-12-27 2020-07-07 华东理工大学 一种缩酚酸环醚类化合物及其制备方法与用途
BR112023020979A2 (pt) * 2021-04-10 2023-12-12 Sunovion Pharmaceuticals Inc Moduladores de taar1 e de serotonina e composições farmacêuticas e métodos para usá-los

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES274327A1 (es) * 1961-01-30 1962-06-01 Geigy Ag J R Procedimiento para la preparacion de nuevos compuestos de 1,5-benzodioxepano
FR1312891A (fr) * 1962-01-29 1962-12-21 Geigy Ag J R Nouveaux 1.5-benzo-dioxépannes et leur préparation
FR1312889A (fr) * 1962-01-29 1962-12-21 Geigy Ag J R Nouveaux benzo-dioxépannes et leur préparation
US3821249A (en) * 1970-03-13 1974-06-28 En Nom Collectif Science Union Dibenzothiazefin derivatives
US3758528A (en) * 1970-03-13 1973-09-11 Science Union & Cie Tricyclic compounds
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
US4335122A (en) * 1981-03-18 1982-06-15 Hoechst-Roussel Pharmaceuticals Inc. Dihydro-dibenzoxepines-thiepines and -morphanthridones, compositions and use

Also Published As

Publication number Publication date
SU1106444A3 (ru) 1984-07-30
ES500942A0 (es) 1983-06-01
PT72833A (fr) 1981-05-01
DK159981A (da) 1981-10-11
AU6934081A (en) 1981-10-15
FI811059L (fi) 1981-10-11
EP0041410B1 (fr) 1983-11-09
MA19113A1 (fr) 1981-12-31
ES519463A0 (es) 1983-11-16
ZA812379B (en) 1982-04-28
DD158242A5 (de) 1983-01-05
DE3161358D1 (en) 1983-12-15
YU92481A (en) 1984-02-29
US4459306A (en) 1984-07-10
OA06779A (fr) 1982-12-31
GR75194B (enExample) 1984-07-13
AR229026A1 (es) 1983-05-31
IL62622A (en) 1984-10-31
ATE5257T1 (de) 1983-11-15
NO811229L (no) 1981-10-12
ES8400742A1 (es) 1983-11-16
IL62622A0 (en) 1981-06-29
NZ196774A (en) 1983-09-30
FI811059A7 (fi) 1981-10-11
JPS56158780A (en) 1981-12-07
ES8306483A1 (es) 1983-06-01
CA1181068A (fr) 1985-01-15
FR2480283A1 (fr) 1981-10-16
PT72833B (fr) 1982-07-26
JPS6116394B2 (enExample) 1986-04-30
FR2480283B1 (enExample) 1983-09-23
EP0041410A1 (fr) 1981-12-09

Similar Documents

Publication Publication Date Title
AU542145B2 (en) make
AU537992B2 (en) Polusilanes
AU535792B2 (en) l
AU538782B2 (en) Triazoloquinoxalin-4-ones
AU536754B2 (en) Imidodisulfamides
AU6633881A (en) Antigingivites composition
AU7208481A (en) Quinoxalinyloxy ethers
AU3206284A (en) 2-guanidno-4-heteroarylthiazoles
AU6934081A (en) Tricyclic ethers
AU6856581A (en) Metal-amine-carboxylates
AU561272B2 (en) Substituted pyridyl-phenyl ethers
AU6591180A (en) Indoxylmaltodextrins
AU527275B2 (en) Auto-diaphragm hemodialyser
AU537824B2 (en) Oxygensensor
AU549968B2 (en) Glycosylglucans
AU6877481A (en) Pyrimidyl-quinazolines
AU7064081A (en) 2-nitroimidazoles
AU7139981A (en) N6-carboxylalkyladenosines
AU540787B2 (en) 4-indenyl-alkyl-piperidenes
AU7475081A (en) 5-amino-tetrazoles
AU534814B2 (en) Showstand
AU537073B2 (en) Haloacetanilide
AU517843B2 (en) Guanylamidines
AU538427B2 (en) Dichlorobenzoyl-3-phenylpyrazolines
AU538275B2 (en) 4-carbamyloxy-oxazaphosphorins